Endocrinology

Type 1 Diabetes

More in Type 1 Diabetes

Sugary Drinks Tied to 2M Diabetes Cases; Diagnosing LADA; Top GLP-1 for Weight Loss

News and commentary from the endocrinology world

Jan 07, 2025
Endo Break over a computer rendering of a man with illustrated body organs.
Sotagliflozin Rejected for T1D; Thyroid and COVID; Diabetes Drug Price Cut

News and commentary from the endocrinology world

Dec 31, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Endocrinologist Deserts; U.S. Obesity Declines; New Obesity Definition Coming Soon

News and commentary from the endocrinology world

Dec 17, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up

News and commentary from the endocrinology world

Dec 03, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
IG Live December 2: The Weight of Wegovy

How GLP-1 drugs are reshaping medicine

Nov 27, 2024
The advertisement for this Instagram Live event.
Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndrome

News and commentary from the endocrinology world

Nov 26, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
CGM Uptake Very Low for Vulnerable Diabetes Populations

But how to achieve equitable use remains "complicated," says expert

Nov 22, 2024
A photo of a woman taking a reading with her continuous glucose monitor.
75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?

News and commentary from the endocrinology world

Nov 19, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Extended Dosing Intervals Possible With Aflibercept in Diabetic Macular Edema

In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose

Nov 18, 2024
image
16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surge

News and commentary from the endocrinology world

Nov 12, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Slow Start for AI-Assisted Screening for Diabetic Retinopathy Despite Promise

Ophthalmologists hope expanded use will lead to more evaluations in primary clinics

Nov 08, 2024
A photo of diabetic retinopathy.
CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down

News and commentary from the endocrinology world

Nov 05, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes

Data too uncertain to support sotagliflozin in subset with chronic kidney disease, advisors say

Nov 01, 2024
FDA ADCOMM sotagliflozin over a computer rendering of chronic kidney disease.
FDA Staff Not Quite Sold on Sotagliflozin for T1D Patients With CKD

SGLT1/SGLT2 inhibitor has another shot in T1D, but now in more narrow patient population

Oct 30, 2024
FDA ADCOMM sotagliflozin over a computer rendering of chronic kidney disease.
More in Type 1 Diabetes

Continuing Medical Education

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

0.75 CME Credits
Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care

0.50 CME Credits
Examining the Pathophysiology, Burden, and Evolving Treatment Landscape of Acromegaly

0.50 CME Credits
Enhancing Acromegaly Care Through Integration of the Latest Clinical Evidence and Patient-Centered Management

1.00 CME Credits
Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment

0.50 CME Credits
Beyond Statin Therapy: Evidence-Based Strategies and Advanced Therapeutic Approaches to Hyperlipidemia Management

1.25 CME Credits
Navigating the Latest Evidence and Guidelines in HIV Treatment: International Perspectives on Individualizing Care

0.75 CME Credits
Aligning Clinical Practices With the Latest Evidence in Management of Comorbidities and Complications in People With Cystic Fibrosis